Subscribe
Magazine
Past Issues
Surveys
Industry Statistics
About Us
Members Only
Best Places to Work
General Interest
Exploration & Development
Drilling & Production
Refining & Processing
Pipelines & Transportation
LNG
Energy Transition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
PennEnergy Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
Next >
Biogen beats expectations, hikes outlook as Alzheimer's drug Leqembi and other new products gain traction
August 01, 2024
Tags
Health care industry
Earnings
Biotech and Pharmaceuticals
From
CNBC.com News
Patients on Alzheimer's drug Leqembi see benefits over three years, Eisai study says
July 30, 2024
Tags
Science
Pharmaceuticals
Business
From
CNBC.com News
Older GLP-1 drug from Novo Nordisk may slow Alzheimer's disease progression by protecting the brain, study says
July 30, 2024
Tags
Companies
US: News
Biotechnology
From
CNBC.com News
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, Eisai
July 26, 2024
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Jim Cramer says Eli Lilly isn't a 'one trick pony' after FDA advisers endorse its Alzheimer's drug
June 11, 2024
Tags
Business News
U/S/ Markets
Investing
From
CNBC.com News
Cramer's Lightning Round: Bank of America is a buy
May 10, 2024
Tags
Kratos Defense and Security Solutions Inc
stocks
Stock markets
From
CNBC.com News
Biogen tops quarterly profit estimates as cost cuts take hold, Leqembi launch picks up
April 24, 2024
Tags
Business
Pharmaceuticals
Breaking news
From
CNBC.com News
5 things to know before the stock market opens Monday
April 22, 2024
Tags
Microsoft Corp
Raytheon Technologies Corp
Comcast Corp
From
CNBC.com News
Eli Lilly says FDA delays approval of Alzheimer's drug in surprise move
March 08, 2024
Tags
Biogen Inc
Biotechnology
US: News
From
CNBC.com News
Healthy Returns: The launch of breakthrough Alzheimer’s drug Leqembi is off to a slow start
February 20, 2024
Tags
Biogen Inc
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
Biogen revenue and profit shrink on Aduhelm costs, slumping sales of multiple sclerosis therapies
February 13, 2024
Tags
Biotech and Pharmaceuticals
Eisai Co Ltd
Health care industry
From
CNBC.com News
5 things to know before the stock market opens Monday
February 12, 2024
Tags
Investing
Biogen Inc
Coca/Cola Co
From
CNBC.com News
Biogen drops controversial Alzheimer's drug Aduhelm to focus on Leqembi, experimental treatments
January 31, 2024
Tags
Eisai Co Ltd
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
December 20, 2023
Tags
Eisai Co Ltd
Health care industry
Eli Lilly and Co
From
CNBC.com News
5 things to know before the stock market opens Monday
November 06, 2023
Tags
5 Things to Know
Walt Disney Co
Business
From
CNBC.com News
More convenient form of breakthrough Alzheimer's drug Leqembi shows promising results in study
October 25, 2023
Tags
Health care industry
Eisai Co Ltd
Biotech and Pharmaceuticals
From
CNBC.com News
Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug
August 07, 2023
Tags
Pharmaceuticals
Business
Breaking news
From
CNBC.com News
Stocks making the biggest moves premarket: Intel, Roku, Procter & Gamble and more
July 28, 2023
Tags
First Solar Inc
New York Community Bancorp Inc
Pfizer Inc
From
CNBC.com News
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
Alaska Air Group Inc
Zscaler Inc
Market Insider
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Biogen Inc
Biotechnology
Companies
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Eisai Co Ltd
Eli Lilly and Co
Bank of America Corp
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Biotech and Pharmaceuticals
Health care industry
Eli Lilly and Co
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Science
Business
Alzheimer's disease
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Eisai Co Ltd
Health care industry
Regulations
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
Levi Strauss & Co
Breaking News: Markets
Stock markets
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Economy
Biogen Inc
Tesla Inc
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
Biotech and Pharmaceuticals
Social issues
Biogen Inc
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
Health care industry
Eisai Co Ltd
Policy
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Zions Bancorporation NA
Biogen Inc
JD/Com Inc
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
Politics
US Top News and Analysis
Pandemics
From
CNBC.com News
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.